NANBIOSIS

The Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) and the Jesus Usón Minimally Invasive Surgery Center (JUMISC) have been working together since 2010 in different research projects due to the synergies and the complementarity between their platforms. In November 2011, and after a successful career in developing collaborative research projects, the managers of both institutions met in order to study and assess new lines of work. The result was the signing of a scientific and technological cooperation agreement, with the objective of combining efforts and achieving a better planning of the research services and platforms of both institutions.

In this context, the Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine (NANBIOSIS) arises from a joint initiative of the CIBER-BBN and the JUMISC.

These two centers group 27 complementary and coordinated units (7 from the JUMISC and 20 form the CIBER-BBN), located in different institutions, which in turn are distributed through 5 Autonomous Communities: Aragon, Cataluña, Extremadura, Madrid , País Vasco and Valencia.

NANBIOSIS is organized in five platforms:

• Production of Biomolecules,

• Production of Biomaterials and Nanomaterials,

• Preclinical Validation-Tissue, Biomaterial and Surface Characterization,

• Preclinical Validation-Bioimaging, and

• High Performance Computing.